Total Funding
65
62
Total FundingSeries B raised
Growth Score
21 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
99142
Gene+ is a biotechnology company that offers research, panel development, mutation detection, and tumor gene detection services.
- Xin Yi: Founder & CEO
- Ling Yang: Founder & President
About the Company
Gene+ operates in the biotechnology industry, focusing on genetic research and development. The company offers a range of services including gene panel development and mutation detection in peripheral blood. Gene+ also provides Next Generation Sequencing (NGS) services, contributing to the field of oncology. Their Smart Laboratory, known as
Gene+sLab, is another key aspect of their operations. The company is also involved in tumor gene detection, offering precision medicine series, tumor whole process monitoring, and early tumor screening and diagnosis services.
